T1	Participants 25 66	men with locally advanced prostate cancer
T2	Participants 390 485	men treated with RT and androgen deprivation therapy (ADT) for locally advanced prostate cancer
T3	Participants 495 572	Between 1987 and 1992, 945 eligible men with locally advanced prostate cancer
T4	Participants 1632 1673	men with locally advanced prostate cancer
